BBOTVSBGM• 28 Days (Normalized)
BBOT vs BGM (BridgeBio Oncology Therapeutics Inc. vs BGM Group Ltd.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.09%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
BGM Performance $9.34
+3109.62%
BGM Group Ltd.
Normalized Baseline0.00%
Alpha Spread Margin BGM LEADS
-3165.71 pts
BGM outperforming by 3165.71 percentage points
BBOTBGM
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT BGM
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | BBOT Price | BBOT Gain (%) | BGM Price | BGM Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.09% | $9.34 | +3109.62% | -3165.71% |
| Sep 30, 2026 | $4.10 | -53.72% | $- | - | |
| Sep 29, 2026 | $3.92 | -55.76% | $0.26 | -11.10% | -44.66% |
| Sep 28, 2026 | $3.81 | -57.00% | $0.24 | -16.15% | -40.85% |
| Sep 25, 2026 | $3.95 | -55.42% | $0.24 | -17.53% | -37.89% |
| Sep 24, 2026 | $3.99 | -54.97% | $0.25 | -14.43% | -40.54% |
| Sep 23, 2026 | $4.16 | -53.05% | $0.26 | -12.37% | -40.68% |
| Sep 22, 2026 | $4.66 | -47.40% | $0.26 | -12.20% | -35.20% |
| Sep 21, 2026 | $4.66 | -47.40% | $0.26 | -12.03% | -35.37% |
| Sep 18, 2026 | $4.77 | -46.16% | $0.25 | -13.75% | -32.41% |
| Sep 17, 2026 | $4.89 | -44.81% | $0.26 | -11.00% | -33.81% |
| Sep 16, 2026 | $4.76 | -46.28% | $0.26 | -11.34% | -34.94% |
| Sep 15, 2026 | $4.88 | -44.92% | $0.25 | -15.12% | -29.80% |
| Sep 14, 2026 | $5.05 | -43.00% | $0.26 | -12.37% | -30.63% |
| Sep 11, 2026 | $4.95 | -44.13% | $0.26 | -9.62% | -34.51% |
Page 1 of 2